# Caterpillar Inc. timeline

entity: /record/caterpillar.md  
id: ent_caterpillar  

Caterpillar Inc.'s timeline holds 499 claims from 2006 to 2026: 491 money & deals, 8 other. 8 are undated. The latest took effect on September 30, 2026.

Kinds: People 0 (/timelines/caterpillar.md?kind=people) · Money & deals 491 (/timelines/caterpillar.md?kind=money) · Products 0 (/timelines/caterpillar.md?kind=products) · Models 0 (/timelines/caterpillar.md?kind=models) · Other 8 (/timelines/caterpillar.md?kind=other)  
Format: date | kind | predicate | value | status | claim.

## 2006

- 2006-12-31 to 2007-12-31 | money | cash_and_equivalents | 530,000,000 United States dollar | superseded | [clm_75317BF68657](/claim/clm_75317BF68657.md)
- 2006-12-31 to 2007-12-31 | money | total_equity | 6,937,000,000 United States dollar | superseded | [clm_C36AC00DE533](/claim/clm_C36AC00DE533.md)

## 2007

- 2007-12-31 to 2008-06-30 | money | cash_and_equivalents | 1,122,000,000 United States dollar | superseded | [clm_6D6136F2BE40](/claim/clm_6D6136F2BE40.md)
- 2007-12-31 to 2008-12-31 | money | net_income | 3,541,000,000 United States dollar | superseded | [clm_33E489BBBD8E](/claim/clm_33E489BBBD8E.md)
- 2007-12-31 to 2008-12-31 | money | operating_income | 4,921,000,000 United States dollar | superseded | [clm_D0C1E8AA6E20](/claim/clm_D0C1E8AA6E20.md)
- 2007-12-31 to 2008-12-31 | money | research_and_development | 1,404,000,000 United States dollar | superseded | [clm_24C25283FD71](/claim/clm_24C25283FD71.md)
- 2007-12-31 to 2008-12-31 | money | revenue | 44,958,000,000 United States dollar | superseded | [clm_DB8F46D84D02](/claim/clm_DB8F46D84D02.md)
- 2007-12-31 to 2008-12-31 | money | total_assets | 56,132,000,000 United States dollar | superseded | [clm_32750CFF8F1C](/claim/clm_32750CFF8F1C.md)
- 2007-12-31 to 2008-06-30 | money | total_equity | 8,996,000,000 United States dollar | superseded | [clm_069394D773C9](/claim/clm_069394D773C9.md)

## 2008

- 2008-06-30 to 2008-09-30 | money | cash_and_equivalents | 782,000,000 United States dollar | superseded | [clm_B90B581FD0DA](/claim/clm_B90B581FD0DA.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_net_income | 1,106,000,000 United States dollar | superseded | [clm_75694513AB4A](/claim/clm_75694513AB4A.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_operating_income | 1,525,000,000 United States dollar | superseded | [clm_D5701FE2C978](/claim/clm_D5701FE2C978.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_research_and_development | -415,000,000 United States dollar | superseded | [clm_57EF357A1509](/claim/clm_57EF357A1509.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_revenue | 13,624,000,000 United States dollar | superseded | [clm_6B50279FCC1A](/claim/clm_6B50279FCC1A.md)
- 2008-06-30 to 2008-09-30 | money | total_equity | 9,583,000,000 United States dollar | superseded | [clm_B8D467835E95](/claim/clm_B8D467835E95.md)
- 2008-09-30 to 2008-12-31 | money | cash_and_equivalents | 2,138,000,000 United States dollar | superseded | [clm_EBA8DEB909F2](/claim/clm_EBA8DEB909F2.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_net_income | 868,000,000 United States dollar | superseded | [clm_277005AA996F](/claim/clm_277005AA996F.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_operating_income | 1,173,000,000 United States dollar | superseded | [clm_553CE52AF817](/claim/clm_553CE52AF817.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_research_and_development | 437,000,000 United States dollar | superseded | [clm_85B11972188C](/claim/clm_85B11972188C.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_revenue | 12,981,000,000 United States dollar | superseded | [clm_7389B7FE31C6](/claim/clm_7389B7FE31C6.md)
- 2008-09-30 to 2008-12-31 | money | total_equity | 9,760,000,000 United States dollar | superseded | [clm_CF8F02023E0C](/claim/clm_CF8F02023E0C.md)
- 2008-12-31 to 2009-03-31 | money | cash_and_equivalents | 2,736,000,000 United States dollar | superseded | [clm_0749E17717AB](/claim/clm_0749E17717AB.md)
- 2008-12-31 to 2009-12-31 | money | net_income | 3,557,000,000 United States dollar | superseded | [clm_41C830E5E45E](/claim/clm_41C830E5E45E.md)
- 2008-12-31 to 2009-12-31 | money | operating_income | 4,448,000,000 United States dollar | superseded | [clm_B9B79C939C77](/claim/clm_B9B79C939C77.md)
- 2008-12-31 to 2009-12-31 | money | research_and_development | 1,728,000,000 United States dollar | superseded | [clm_F9CC57CE389A](/claim/clm_F9CC57CE389A.md)
- 2008-12-31 to 2009-12-31 | money | revenue | 51,324,000,000 United States dollar | superseded | [clm_324967563B05](/claim/clm_324967563B05.md)
- 2008-12-31 to 2009-06-30 | money | total_assets | 67,782,000,000 United States dollar | superseded | [clm_84064A05FC17](/claim/clm_84064A05FC17.md)
- 2008-12-31 to 2009-03-31 | money | total_equity | 6,190,000,000 United States dollar | superseded | [clm_C1C1CFD1D337](/claim/clm_C1C1CFD1D337.md)

## 2009

- 2009-03-31 to 2009-06-30 | money | cash_and_equivalents | 3,566,000,000 United States dollar | superseded | [clm_EB865E85BBED](/claim/clm_EB865E85BBED.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_net_income | -112,000,000 United States dollar | superseded | [clm_D89D49552211](/claim/clm_D89D49552211.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_operating_income | -175,000,000 United States dollar | superseded | [clm_01FB61319CD4](/claim/clm_01FB61319CD4.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_research_and_development | 388,000,000 United States dollar | superseded | [clm_3B3281DBFCB4](/claim/clm_3B3281DBFCB4.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_revenue | 9,225,000,000 United States dollar | superseded | [clm_F83FA70B66AF](/claim/clm_F83FA70B66AF.md)
- 2009-03-31 to 2009-06-30 | money | total_equity | 6,336,000,000 United States dollar | superseded | [clm_540539B34A20](/claim/clm_540539B34A20.md)
- 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 3,991,000,000 United States dollar | superseded | [clm_D06037DC8941](/claim/clm_D06037DC8941.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_net_income | 371,000,000 United States dollar | superseded | [clm_A85CADA89871](/claim/clm_A85CADA89871.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_operating_income | 347,000,000 United States dollar | superseded | [clm_C1318B59FE2C](/claim/clm_C1318B59FE2C.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_research_and_development | -351,000,000 United States dollar | superseded | [clm_8CBA654BADFA](/claim/clm_8CBA654BADFA.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_revenue | 7,975,000,000 United States dollar | superseded | [clm_A943453A8BEC](/claim/clm_A943453A8BEC.md)
- 2009-06-30 to 2009-09-30 | money | shares_outstanding | 621,293,542 shares | superseded | [clm_8B8B9EB85244](/claim/clm_8B8B9EB85244.md)
- 2009-06-30 to 2009-09-30 | money | total_assets | 62,092,000,000 United States dollar | superseded | [clm_9865693782B3](/claim/clm_9865693782B3.md)
- 2009-06-30 to 2009-09-30 | money | total_equity | 7,375,000,000 United States dollar | superseded | [clm_EF6841AA5AA4](/claim/clm_EF6841AA5AA4.md)
- 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 4,188,000,000 United States dollar | superseded | [clm_92F836C72025](/claim/clm_92F836C72025.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_net_income | 404,000,000 United States dollar | superseded | [clm_9C0A150282C2](/claim/clm_9C0A150282C2.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_operating_income | 277,000,000 United States dollar | superseded | [clm_F32D575FFEE6](/claim/clm_F32D575FFEE6.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_research_and_development | 327,000,000 United States dollar | superseded | [clm_3C8F9D1E6E27](/claim/clm_3C8F9D1E6E27.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_revenue | 7,298,000,000 United States dollar | superseded | [clm_4BEB119B9E99](/claim/clm_4BEB119B9E99.md)
- 2009-09-30 to 2009-12-31 | money | shares_outstanding | 622,727,557 shares | superseded | [clm_D989D6B5234B](/claim/clm_D989D6B5234B.md)
- 2009-09-30 to 2009-12-31 | money | total_assets | 60,838,000,000 United States dollar | superseded | [clm_346C5A782984](/claim/clm_346C5A782984.md)
- 2009-09-30 to 2009-12-31 | money | total_equity | 8,082,000,000 United States dollar | superseded | [clm_70C5D80FB244](/claim/clm_70C5D80FB244.md)
- 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 4,867,000,000 United States dollar | superseded | [clm_6836FE78CE3D](/claim/clm_6836FE78CE3D.md)
- 2009-12-31 to 2010-12-31 | money | net_income | 895,000,000 United States dollar | superseded | [clm_C109CA4DF56A](/claim/clm_C109CA4DF56A.md)
- 2009-12-31 to 2010-12-31 | money | operating_income | 577,000,000 United States dollar | superseded | [clm_955D9B01AE1F](/claim/clm_955D9B01AE1F.md)
- 2009-12-31 to 2010-12-31 | money | research_and_development | 1,421,000,000 United States dollar | superseded | [clm_7975B3525BF1](/claim/clm_7975B3525BF1.md)
- 2009-12-31 to 2010-12-31 | money | revenue | 32,396,000,000 United States dollar | superseded | [clm_0AE6E00A3ACE](/claim/clm_0AE6E00A3ACE.md)
- 2009-12-31 to 2010-03-31 | money | shares_outstanding | 624,722,719 shares | superseded | [clm_81D53ACD5BA3](/claim/clm_81D53ACD5BA3.md)
- 2009-12-31 to 2010-03-31 | money | total_assets | 60,038,000,000 United States dollar | superseded | [clm_1F36E81C720E](/claim/clm_1F36E81C720E.md)
- 2009-12-31 to 2010-03-31 | money | total_equity | 8,823,000,000 United States dollar | superseded | [clm_A3B93167CDA2](/claim/clm_A3B93167CDA2.md)

## 2010

- 2010-03-31 to 2020-12-31 | money | cash_and_equivalents | 3,538,000,000 United States dollar | superseded | [clm_871EC1A628C4](/claim/clm_871EC1A628C4.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_net_income | 233,000,000 United States dollar | superseded | [clm_14F8CAD65274](/claim/clm_14F8CAD65274.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_operating_income | 508,000,000 United States dollar | superseded | [clm_23A7F1FCD7F3](/claim/clm_23A7F1FCD7F3.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_research_and_development | 402,000,000 United States dollar | superseded | [clm_3FCB9CB7F3E4](/claim/clm_3FCB9CB7F3E4.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_revenue | 8,238,000,000 United States dollar | superseded | [clm_920A93192C23](/claim/clm_920A93192C23.md)
- 2010-03-31 to 2010-06-30 | money | shares_outstanding | 627,745,394 shares | superseded | [clm_B9E46308D7DB](/claim/clm_B9E46308D7DB.md)
- 2010-03-31 to 2010-06-30 | money | total_assets | 58,836,000,000 United States dollar | superseded | [clm_28350916E999](/claim/clm_28350916E999.md)
- 2010-03-31 to 2010-06-30 | money | total_equity | 9,022,000,000 United States dollar | superseded | [clm_74AA18A73248](/claim/clm_74AA18A73248.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_net_income | 707,000,000 United States dollar | superseded | [clm_215717B2D09D](/claim/clm_215717B2D09D.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_operating_income | 977,000,000 United States dollar | superseded | [clm_FC764B93BBD3](/claim/clm_FC764B93BBD3.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_research_and_development | 450,000,000 United States dollar | superseded | [clm_7A813DFA1AA1](/claim/clm_7A813DFA1AA1.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_revenue | 10,409,000,000 United States dollar | superseded | [clm_272F1C1F84A9](/claim/clm_272F1C1F84A9.md)
- 2010-06-30 to 2010-09-30 | money | shares_outstanding | 630,472,409 shares | superseded | [clm_5035B88C1B02](/claim/clm_5035B88C1B02.md)
- 2010-06-30 to 2010-09-30 | money | total_assets | 58,793,000,000 United States dollar | superseded | [clm_8F08016A77E2](/claim/clm_8F08016A77E2.md)
- 2010-06-30 to 2010-09-30 | money | total_equity | 9,272,000,000 United States dollar | superseded | [clm_6F11B1559A85](/claim/clm_6F11B1559A85.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_net_income | 792,000,000 United States dollar | superseded | [clm_854652B3C20C](/claim/clm_854652B3C20C.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_operating_income | 1,187,000,000 United States dollar | superseded | [clm_DED4E67DA250](/claim/clm_DED4E67DA250.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_research_and_development | 510,000,000 United States dollar | superseded | [clm_D44F08D4C7C3](/claim/clm_D44F08D4C7C3.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_revenue | 11,134,000,000 United States dollar | superseded | [clm_A128D1ED3F5D](/claim/clm_A128D1ED3F5D.md)
- 2010-09-30 to 2010-12-31 | money | shares_outstanding | 634,702,801 shares | superseded | [clm_04CF8B131C0D](/claim/clm_04CF8B131C0D.md)
- 2010-09-30 to 2010-12-31 | money | total_assets | 61,642,000,000 United States dollar | superseded | [clm_2D4681E2AA41](/claim/clm_2D4681E2AA41.md)
- 2010-09-30 to 2010-12-31 | money | total_equity | 9,875,000,000 United States dollar | superseded | [clm_404ADD62BF5F](/claim/clm_404ADD62BF5F.md)
- 2010-12-31 | money | net_income | 2,700,000,000 United States dollar | valid | [clm_26305D056517](/claim/clm_26305D056517.md)
- 2010-12-31 to 2011-12-31 | money | operating_income | 3,963,000,000 United States dollar | superseded | [clm_E277D9FD17F0](/claim/clm_E277D9FD17F0.md)
- 2010-12-31 to 2011-12-31 | money | research_and_development | 1,905,000,000 United States dollar | superseded | [clm_19045BF97802](/claim/clm_19045BF97802.md)
- 2010-12-31 to 2011-12-31 | money | revenue | 42,588,000,000 United States dollar | superseded | [clm_45D82FE7A86B](/claim/clm_45D82FE7A86B.md)
- 2010-12-31 to 2011-03-31 | money | shares_outstanding | 638,822,714 shares | superseded | [clm_A396EBE4DB53](/claim/clm_A396EBE4DB53.md)
- 2010-12-31 to 2011-03-31 | money | total_assets | 64,020,000,000 United States dollar | superseded | [clm_89321CD47451](/claim/clm_89321CD47451.md)
- 2010-12-31 to 2011-03-31 | money | total_equity | 10,864,000,000 United States dollar | superseded | [clm_1E5A3F1E4101](/claim/clm_1E5A3F1E4101.md)

## 2011

- 2011-03-31 to 2011-06-30 | money | quarterly_net_income | 1,225,000,000 United States dollar | superseded | [clm_862CCB5E5EEF](/claim/clm_862CCB5E5EEF.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_operating_income | 1,833,000,000 United States dollar | superseded | [clm_DE2C85C9AD7E](/claim/clm_DE2C85C9AD7E.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_research_and_development | 525,000,000 United States dollar | superseded | [clm_FF4C8593BFF4](/claim/clm_FF4C8593BFF4.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_revenue | 12,949,000,000 United States dollar | superseded | [clm_8733D5C8BDD5](/claim/clm_8733D5C8BDD5.md)
- 2011-03-31 to 2011-06-30 | money | shares_outstanding | 644,452,020 shares | superseded | [clm_2A920919D88B](/claim/clm_2A920919D88B.md)
- 2011-03-31 to 2011-06-30 | money | total_assets | 66,387,000,000 United States dollar | superseded | [clm_85E832EE1424](/claim/clm_85E832EE1424.md)
- 2011-03-31 to 2011-06-30 | money | total_equity | 12,672,000,000 United States dollar | superseded | [clm_E1F0D776DD9C](/claim/clm_E1F0D776DD9C.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_net_income | 1,015,000,000 United States dollar | superseded | [clm_C7843ACF51E9](/claim/clm_C7843ACF51E9.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_operating_income | 1,601,000,000 United States dollar | superseded | [clm_6743EA2E10F6](/claim/clm_6743EA2E10F6.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_research_and_development | 584,000,000 United States dollar | superseded | [clm_47DC0BE6385B](/claim/clm_47DC0BE6385B.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_revenue | 14,230,000,000 United States dollar | superseded | [clm_BA0EDA202023](/claim/clm_BA0EDA202023.md)
- 2011-06-30 to 2011-09-30 | money | shares_outstanding | 646,066,322 shares | superseded | [clm_3A7699087984](/claim/clm_3A7699087984.md)
- 2011-06-30 to 2011-09-30 | money | total_assets | 73,611,000,000 United States dollar | superseded | [clm_A3F5BFEF1471](/claim/clm_A3F5BFEF1471.md)
- 2011-06-30 to 2011-09-30 | money | total_equity | 13,436,000,000 United States dollar | superseded | [clm_36F5DF7AB384](/claim/clm_36F5DF7AB384.md)
- 2011-09-30 | money | quarterly_net_income | 1,141,000,000 United States dollar | valid | [clm_B5DCF17B952C](/claim/clm_B5DCF17B952C.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_operating_income | 1,759,000,000 United States dollar | superseded | [clm_C6340BA02161](/claim/clm_C6340BA02161.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_research_and_development | 584,000,000 United States dollar | superseded | [clm_A9382290D456](/claim/clm_A9382290D456.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_revenue | 15,716,000,000 United States dollar | superseded | [clm_DD61293C7F45](/claim/clm_DD61293C7F45.md)
- 2011-09-30 to 2011-12-31 | money | shares_outstanding | 646,620,369 shares | superseded | [clm_C2D9F7E3E146](/claim/clm_C2D9F7E3E146.md)
- 2011-09-30 to 2011-12-31 | money | total_assets | 77,767,000,000 United States dollar | superseded | [clm_6194F2ACCDF1](/claim/clm_6194F2ACCDF1.md)
- 2011-09-30 to 2011-12-31 | money | total_equity | 14,213,000,000 United States dollar | superseded | [clm_A76199634DEB](/claim/clm_A76199634DEB.md)
- 2011-12-31 to 2012-12-31 | money | operating_income | 7,153,000,000 United States dollar | superseded | [clm_3FDCF40A07E6](/claim/clm_3FDCF40A07E6.md)
- 2011-12-31 to 2012-12-31 | money | research_and_development | 2,297,000,000 United States dollar | superseded | [clm_3B2F9E6C6894](/claim/clm_3B2F9E6C6894.md)
- 2011-12-31 to 2012-12-31 | money | revenue | 60,138,000,000 United States dollar | superseded | [clm_3BC2D1159D56](/claim/clm_3BC2D1159D56.md)
- 2011-12-31 to 2012-03-31 | money | shares_outstanding | 647,533,344 shares | superseded | [clm_DC75CC292FC3](/claim/clm_DC75CC292FC3.md)
- 2011-12-31 to 2012-03-31 | money | total_assets | 81,446,000,000 United States dollar | superseded | [clm_4817AE16F486](/claim/clm_4817AE16F486.md)
- 2011-12-31 to 2012-03-31 | money | total_equity | 12,929,000,000 United States dollar | superseded | [clm_581BEE9C49AA](/claim/clm_581BEE9C49AA.md)

## 2012

- 2012-03-31 to 2012-06-30 | money | quarterly_operating_income | 2,323,000,000 United States dollar | superseded | [clm_55DD3ECAFBC9](/claim/clm_55DD3ECAFBC9.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_research_and_development | 587,000,000 United States dollar | superseded | [clm_617BD67CD422](/claim/clm_617BD67CD422.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_revenue | 15,981,000,000 United States dollar | superseded | [clm_550240290D84](/claim/clm_550240290D84.md)
- 2012-03-31 to 2012-06-30 | money | shares_outstanding | 652,337,920 shares | superseded | [clm_EF8AAE2B407A](/claim/clm_EF8AAE2B407A.md)
- 2012-03-31 to 2012-06-30 | money | total_assets | 83,908,000,000 United States dollar | superseded | [clm_373777A5A74E](/claim/clm_373777A5A74E.md)
- 2012-03-31 to 2012-06-30 | money | total_equity | 15,016,000,000 United States dollar | superseded | [clm_FB45596F3506](/claim/clm_FB45596F3506.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_operating_income | 2,616,000,000 United States dollar | superseded | [clm_061696346A95](/claim/clm_061696346A95.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_research_and_development | 632,000,000 United States dollar | superseded | [clm_19A0D1306BD2](/claim/clm_19A0D1306BD2.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_revenue | 17,374,000,000 United States dollar | superseded | [clm_CCD06286C77B](/claim/clm_CCD06286C77B.md)
- 2012-06-30 to 2012-09-30 | money | shares_outstanding | 653,268,696 shares | superseded | [clm_EBB1EAF99A3E](/claim/clm_EBB1EAF99A3E.md)
- 2012-06-30 to 2012-09-30 | money | total_assets | 88,838,000,000 United States dollar | superseded | [clm_4DE434376F3C](/claim/clm_4DE434376F3C.md)
- 2012-06-30 to 2012-09-30 | money | total_equity | 15,981,000,000 United States dollar | superseded | [clm_EDCF635A8ADF](/claim/clm_EDCF635A8ADF.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_operating_income | 2,596,000,000 United States dollar | superseded | [clm_06552AEBE71E](/claim/clm_06552AEBE71E.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_research_and_development | 634,000,000 United States dollar | superseded | [clm_4983FFE44002](/claim/clm_4983FFE44002.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_revenue | 16,445,000,000 United States dollar | superseded | [clm_FB1D9CAFEB5D](/claim/clm_FB1D9CAFEB5D.md)
- 2012-09-30 to 2012-12-31 | money | shares_outstanding | 653,933,672 shares | superseded | [clm_D49219D439F3](/claim/clm_D49219D439F3.md)
- 2012-09-30 to 2012-12-31 | money | total_assets | 90,541,000,000 United States dollar | superseded | [clm_50665B623010](/claim/clm_50665B623010.md)
- 2012-09-30 to 2012-12-31 | money | total_equity | 17,936,000,000 United States dollar | superseded | [clm_A287D98D1990](/claim/clm_A287D98D1990.md)
- 2012-12-31 to 2013-12-31 | money | operating_income | 8,573,000,000 United States dollar | superseded | [clm_AA6FDBF61DDD](/claim/clm_AA6FDBF61DDD.md)
- 2012-12-31 to 2013-12-31 | money | research_and_development | 2,466,000,000 United States dollar | superseded | [clm_E8DE334B74B5](/claim/clm_E8DE334B74B5.md)
- 2012-12-31 to 2013-12-31 | money | revenue | 65,875,000,000 United States dollar | superseded | [clm_AD10E954FC82](/claim/clm_AD10E954FC82.md)
- 2012-12-31 to 2013-03-31 | money | shares_outstanding | 655,048,493 shares | superseded | [clm_0AE8E0D6BD95](/claim/clm_0AE8E0D6BD95.md)
- 2012-12-31 to 2013-03-31 | money | total_assets | 89,356,000,000 United States dollar | superseded | [clm_965A8F301BD9](/claim/clm_965A8F301BD9.md)
- 2012-12-31 to 2013-03-31 | money | total_equity | 17,582,000,000 United States dollar | superseded | [clm_2D96B53AF1DE](/claim/clm_2D96B53AF1DE.md)

## 2013

- 2013-03-31 to 2013-06-30 | money | quarterly_operating_income | 1,218,000,000 United States dollar | superseded | [clm_B9AEEB05BA91](/claim/clm_B9AEEB05BA91.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_research_and_development | 562,000,000 United States dollar | superseded | [clm_0B84A9F5D857](/claim/clm_0B84A9F5D857.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_revenue | 13,210,000,000 United States dollar | superseded | [clm_F8EC3AFCA35C](/claim/clm_F8EC3AFCA35C.md)
- 2013-03-31 to 2013-06-30 | money | shares_outstanding | 657,484,946 shares | superseded | [clm_F1CD2BB7479B](/claim/clm_F1CD2BB7479B.md)
- 2013-03-31 to 2013-06-30 | money | total_assets | 88,743,000,000 United States dollar | superseded | [clm_51281E872F0A](/claim/clm_51281E872F0A.md)
- 2013-03-31 to 2013-06-30 | money | total_equity | 18,318,000,000 United States dollar | superseded | [clm_A4D792B2ACD1](/claim/clm_A4D792B2ACD1.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_operating_income | 1,557,000,000 United States dollar | superseded | [clm_F062F9F7E635](/claim/clm_F062F9F7E635.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_research_and_development | 548,000,000 United States dollar | superseded | [clm_0252543709CD](/claim/clm_0252543709CD.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_revenue | 14,621,000,000 United States dollar | superseded | [clm_2857AC9F5FAD](/claim/clm_2857AC9F5FAD.md)
- 2013-06-30 to 2013-09-30 | money | shares_outstanding | 647,615,068 shares | superseded | [clm_6779EE795B23](/claim/clm_6779EE795B23.md)
- 2013-06-30 to 2013-09-30 | money | total_assets | 87,375,000,000 United States dollar | superseded | [clm_5B21FEDAC140](/claim/clm_5B21FEDAC140.md)
- 2013-06-30 to 2013-09-30 | money | total_equity | 17,678,000,000 United States dollar | superseded | [clm_7145CF876BFD](/claim/clm_7145CF876BFD.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_operating_income | 1,401,000,000 United States dollar | superseded | [clm_434D93FAA3CA](/claim/clm_434D93FAA3CA.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_research_and_development | 469,000,000 United States dollar | superseded | [clm_894A8820E39F](/claim/clm_894A8820E39F.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_revenue | 13,423,000,000 United States dollar | superseded | [clm_180AC610829B](/claim/clm_180AC610829B.md)
- 2013-09-30 to 2013-12-31 | money | shares_outstanding | 636,355,991 shares | superseded | [clm_D5D5857EC612](/claim/clm_D5D5857EC612.md)
- 2013-09-30 to 2013-12-31 | money | total_assets | 87,272,000,000 United States dollar | superseded | [clm_77155967F30E](/claim/clm_77155967F30E.md)
- 2013-09-30 to 2013-12-31 | money | total_equity | 18,177,000,000 United States dollar | superseded | [clm_6729827223A3](/claim/clm_6729827223A3.md)
- 2013-12-31 to 2014-12-31 | money | operating_income | 5,628,000,000 United States dollar | superseded | [clm_34584E0D2909](/claim/clm_34584E0D2909.md)
- 2013-12-31 to 2014-12-31 | money | research_and_development | 2,046,000,000 United States dollar | superseded | [clm_839335C92AA3](/claim/clm_839335C92AA3.md)
- 2013-12-31 to 2014-12-31 | money | revenue | 55,656,000,000 United States dollar | superseded | [clm_210C72EBA749](/claim/clm_210C72EBA749.md)
- 2013-12-31 to 2014-03-31 | money | shares_outstanding | 637,822,342 shares | superseded | [clm_D488D8FF8F77](/claim/clm_D488D8FF8F77.md)
- 2013-12-31 to 2014-03-31 | money | total_assets | 84,896,000,000 United States dollar | superseded | [clm_F36F8B95796F](/claim/clm_F36F8B95796F.md)
- 2013-12-31 to 2014-03-31 | money | total_equity | 20,878,000,000 United States dollar | superseded | [clm_280DC21487E9](/claim/clm_280DC21487E9.md)

## 2014

- 2014-03-31 to 2014-06-30 | money | quarterly_operating_income | 1,398,000,000 United States dollar | superseded | [clm_B42507B9B428](/claim/clm_B42507B9B428.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_research_and_development | 508,000,000 United States dollar | superseded | [clm_658861A6AABD](/claim/clm_658861A6AABD.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_revenue | 13,241,000,000 United States dollar | superseded | [clm_7EA71EE5D6F8](/claim/clm_7EA71EE5D6F8.md)
- 2014-03-31 to 2014-06-30 | money | shares_outstanding | 624,233,901 shares | superseded | [clm_B181A211D233](/claim/clm_B181A211D233.md)
- 2014-03-31 to 2014-06-30 | money | total_assets | 84,397,000,000 United States dollar | superseded | [clm_8064E4449E50](/claim/clm_8064E4449E50.md)
- 2014-03-31 to 2014-06-30 | money | total_equity | 20,369,000,000 United States dollar | superseded | [clm_E618E498A2B8](/claim/clm_E618E498A2B8.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_operating_income | 1,475,000,000 United States dollar | superseded | [clm_0E27876D140E](/claim/clm_0E27876D140E.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_research_and_development | 516,000,000 United States dollar | superseded | [clm_350027411127](/claim/clm_350027411127.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_revenue | 14,150,000,000 United States dollar | superseded | [clm_AC7BBA3024C5](/claim/clm_AC7BBA3024C5.md)
- 2014-06-30 to 2014-09-30 | money | shares_outstanding | 627,846,602 shares | superseded | [clm_46444D523CC0](/claim/clm_46444D523CC0.md)
- 2014-06-30 to 2014-09-30 | money | total_assets | 87,827,000,000 United States dollar | superseded | [clm_CD9D07E22672](/claim/clm_CD9D07E22672.md)
- 2014-06-30 to 2014-09-30 | money | total_equity | 20,923,000,000 United States dollar | superseded | [clm_A4CF998C2C51](/claim/clm_A4CF998C2C51.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_operating_income | 1,392,000,000 United States dollar | superseded | [clm_DADF30C9B486](/claim/clm_DADF30C9B486.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_research_and_development | 533,000,000 United States dollar | superseded | [clm_AD3E20D65889](/claim/clm_AD3E20D65889.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_revenue | 13,549,000,000 United States dollar | superseded | [clm_245B46F37112](/claim/clm_245B46F37112.md)
- 2014-09-30 to 2014-12-31 | money | shares_outstanding | 605,398,874 shares | superseded | [clm_741A25C4A4D7](/claim/clm_741A25C4A4D7.md)
- 2014-09-30 to 2014-12-31 | money | total_assets | 84,488,000,000 United States dollar | superseded | [clm_E2F5DD371872](/claim/clm_E2F5DD371872.md)
- 2014-09-30 to 2014-12-31 | money | total_equity | 18,896,000,000 United States dollar | superseded | [clm_B95AE9AA77B7](/claim/clm_B95AE9AA77B7.md)
- 2014-12-31 to 2015-12-31 | money | operating_income | 5,328,000,000 United States dollar | superseded | [clm_1FB56175BFD6](/claim/clm_1FB56175BFD6.md)
- 2014-12-31 to 2015-12-31 | money | research_and_development | 2,135,000,000 United States dollar | superseded | [clm_5DF5FD84E9EC](/claim/clm_5DF5FD84E9EC.md)
- 2014-12-31 to 2015-12-31 | money | revenue | 55,184,000,000 United States dollar | superseded | [clm_F0A83CCA3A0D](/claim/clm_F0A83CCA3A0D.md)
- 2014-12-31 to 2015-03-31 | money | shares_outstanding | 606,166,559 shares | superseded | [clm_CC266824996F](/claim/clm_CC266824996F.md)
- 2014-12-31 to 2015-03-31 | money | total_assets | 84,681,000,000 United States dollar | superseded | [clm_F6A695D8D9BC](/claim/clm_F6A695D8D9BC.md)
- 2014-12-31 to 2015-03-31 | money | total_equity | 16,826,000,000 United States dollar | superseded | [clm_2761C146A959](/claim/clm_2761C146A959.md)

## 2015

- 2015-03-31 to 2015-06-30 | money | quarterly_operating_income | 1,527,000,000 United States dollar | superseded | [clm_12ABEE57A2CB](/claim/clm_12ABEE57A2CB.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_research_and_development | 546,000,000 United States dollar | superseded | [clm_66D3739DF8EA](/claim/clm_66D3739DF8EA.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_revenue | 12,702,000,000 United States dollar | superseded | [clm_59330A70C03F](/claim/clm_59330A70C03F.md)
- 2015-03-31 to 2015-06-30 | money | shares_outstanding | 603,643,663 shares | superseded | [clm_EE54C9F54FEC](/claim/clm_EE54C9F54FEC.md)
- 2015-03-31 to 2015-06-30 | money | total_assets | 82,490,000,000 United States dollar | superseded | [clm_741B576168D6](/claim/clm_741B576168D6.md)
- 2015-03-31 to 2015-06-30 | money | total_equity | 17,038,000,000 United States dollar | superseded | [clm_16FFFDD2CA86](/claim/clm_16FFFDD2CA86.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_operating_income | 1,130,000,000 United States dollar | superseded | [clm_E9B2FB548C6D](/claim/clm_E9B2FB548C6D.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_research_and_development | 532,000,000 United States dollar | superseded | [clm_6EFB10C2B8A9](/claim/clm_6EFB10C2B8A9.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_revenue | 12,317,000,000 United States dollar | superseded | [clm_FB7C5FAF31F6](/claim/clm_FB7C5FAF31F6.md)
- 2015-06-30 to 2015-09-30 | money | shares_outstanding | 602,632,543 shares | superseded | [clm_C88D96B70981](/claim/clm_C88D96B70981.md)
- 2015-06-30 to 2015-09-30 | money | total_assets | 82,242,000,000 United States dollar | superseded | [clm_3BF30D2B5C60](/claim/clm_3BF30D2B5C60.md)
- 2015-06-30 to 2015-09-30 | money | total_equity | 17,161,000,000 United States dollar | superseded | [clm_D4E06E5242D9](/claim/clm_D4E06E5242D9.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_operating_income | 713,000,000 United States dollar | superseded | [clm_2EE09891A333](/claim/clm_2EE09891A333.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_research_and_development | 534,000,000 United States dollar | superseded | [clm_7E9F951A7DF0](/claim/clm_7E9F951A7DF0.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_revenue | 10,962,000,000 United States dollar | superseded | [clm_1E8F14662F42](/claim/clm_1E8F14662F42.md)
- 2015-09-30 to 2015-12-31 | money | shares_outstanding | 582,233,801 shares | superseded | [clm_F2D2925ED147](/claim/clm_F2D2925ED147.md)
- 2015-09-30 to 2015-12-31 | money | total_assets | 78,969,000,000 United States dollar | superseded | [clm_6BA6458BD863](/claim/clm_6BA6458BD863.md)
- 2015-09-30 to 2015-12-31 | money | total_equity | 15,968,000,000 United States dollar | superseded | [clm_1682F9783163](/claim/clm_1682F9783163.md)
- 2015-12-31 to 2016-12-31 | money | operating_income | 3,256,000,000 United States dollar | superseded | [clm_6A35A52CD148](/claim/clm_6A35A52CD148.md)
- 2015-12-31 to 2016-12-31 | money | research_and_development | 2,165,000,000 United States dollar | superseded | [clm_A6B19FB7FE09](/claim/clm_A6B19FB7FE09.md)
- 2015-12-31 to 2016-12-31 | money | revenue | 47,011,000,000 United States dollar | superseded | [clm_4529B49861B3](/claim/clm_4529B49861B3.md)
- 2015-12-31 to 2016-03-31 | money | shares_outstanding | 582,321,890 shares | superseded | [clm_637228CC53F8](/claim/clm_637228CC53F8.md)
- 2015-12-31 to 2016-03-31 | money | total_assets | 78,497,000,000 United States dollar | superseded | [clm_38FF9BAE2A21](/claim/clm_38FF9BAE2A21.md)
- 2015-12-31 to 2016-03-31 | money | total_equity | 14,885,000,000 United States dollar | superseded | [clm_1AE80AF96DCA](/claim/clm_1AE80AF96DCA.md)

## 2016

- 2016-03-31 to 2016-06-30 | money | quarterly_operating_income | 494,000,000 United States dollar | superseded | [clm_F2DA02351B02](/claim/clm_F2DA02351B02.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_research_and_development | 508,000,000 United States dollar | superseded | [clm_857076DAAFCF](/claim/clm_857076DAAFCF.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_revenue | 9,461,000,000 United States dollar | superseded | [clm_C0D1E7336ABB](/claim/clm_C0D1E7336ABB.md)
- 2016-03-31 to 2016-06-30 | money | shares_outstanding | 583,868,746 shares | superseded | [clm_136DF076A740](/claim/clm_136DF076A740.md)
- 2016-03-31 to 2016-06-30 | money | total_assets | 78,307,000,000 United States dollar | superseded | [clm_C5BEDD61ECFA](/claim/clm_C5BEDD61ECFA.md)
- 2016-03-31 to 2016-06-30 | money | total_equity | 15,753,000,000 United States dollar | superseded | [clm_4551A28520B5](/claim/clm_4551A28520B5.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_operating_income | 785,000,000 United States dollar | superseded | [clm_1E77B7E0C3D7](/claim/clm_1E77B7E0C3D7.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_research_and_development | 468,000,000 United States dollar | superseded | [clm_00A1BFB62C4C](/claim/clm_00A1BFB62C4C.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_revenue | 10,342,000,000 United States dollar | superseded | [clm_FFADB6E68ECA](/claim/clm_FFADB6E68ECA.md)
- 2016-06-30 to 2016-09-30 | money | shares_outstanding | 584,231,181 shares | superseded | [clm_04E192844848](/claim/clm_04E192844848.md)
- 2016-06-30 to 2016-09-30 | money | total_assets | 78,300,000,000 United States dollar | superseded | [clm_CD8199744984](/claim/clm_CD8199744984.md)
- 2016-06-30 to 2016-09-30 | money | total_equity | 15,303,000,000 United States dollar | superseded | [clm_4D9181250C06](/claim/clm_4D9181250C06.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_operating_income | 481,000,000 United States dollar | superseded | [clm_705C08D3FCE6](/claim/clm_705C08D3FCE6.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 453,000,000 United States dollar | superseded | [clm_2B9F00775B85](/claim/clm_2B9F00775B85.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 9,160,000,000 United States dollar | superseded | [clm_DAA25F4E09CF](/claim/clm_DAA25F4E09CF.md)
- 2016-09-30 to 2016-12-31 | money | shares_outstanding | 585,072,585 shares | superseded | [clm_A055521A888B](/claim/clm_A055521A888B.md)
- 2016-09-30 to 2016-12-31 | money | total_assets | 76,402,000,000 United States dollar | superseded | [clm_33C989D24868](/claim/clm_33C989D24868.md)
- 2016-09-30 to 2016-12-31 | money | total_equity | 15,715,000,000 United States dollar | superseded | [clm_6FA26240221A](/claim/clm_6FA26240221A.md)
- 2016-12-31 to 2017-12-31 | money | operating_income | 498,000,000 United States dollar | superseded | [clm_D27FE32B19DF](/claim/clm_D27FE32B19DF.md)
- 2016-12-31 to 2017-12-31 | money | research_and_development | 1,951,000,000 United States dollar | superseded | [clm_005521A0C8AF](/claim/clm_005521A0C8AF.md)
- 2016-12-31 to 2017-12-31 | money | revenue | 38,537,000,000 United States dollar | superseded | [clm_C86C1F3D3A93](/claim/clm_C86C1F3D3A93.md)
- 2016-12-31 to 2017-03-31 | money | shares_outstanding | 586,486,024 shares | superseded | [clm_1C1E666A0A5A](/claim/clm_1C1E666A0A5A.md)
- 2016-12-31 to 2017-03-31 | money | total_assets | 74,704,000,000 United States dollar | superseded | [clm_DBCEB7F7E62D](/claim/clm_DBCEB7F7E62D.md)

## 2017

- 2017-01-01 to 2017-03-31 | money | total_equity | 13,228,000,000 United States dollar | superseded | [clm_8DA4B5FABE90](/claim/clm_8DA4B5FABE90.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_operating_income | 417,000,000 United States dollar | superseded | [clm_0B952FD08486](/claim/clm_0B952FD08486.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 418,000,000 United States dollar | superseded | [clm_AD30A35B7096](/claim/clm_AD30A35B7096.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 9,822,000,000 United States dollar | superseded | [clm_E24013220128](/claim/clm_E24013220128.md)
- 2017-03-31 to 2017-06-30 | money | shares_outstanding | 589,090,308 shares | superseded | [clm_733F4FB4E0BF](/claim/clm_733F4FB4E0BF.md)
- 2017-03-31 to 2017-06-30 | money | total_assets | 77,549,000,000 United States dollar | superseded | [clm_7C8E71D77A77](/claim/clm_7C8E71D77A77.md)
- 2017-03-31 to 2017-06-30 | money | total_equity | 13,660,000,000 United States dollar | superseded | [clm_010E2FE5F3C2](/claim/clm_010E2FE5F3C2.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_operating_income | 1,251,000,000 United States dollar | superseded | [clm_B4D844FE15B9](/claim/clm_B4D844FE15B9.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_research_and_development | 453,000,000 United States dollar | superseded | [clm_B18F5D037A50](/claim/clm_B18F5D037A50.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 11,331,000,000 United States dollar | superseded | [clm_ED79A1248BF6](/claim/clm_ED79A1248BF6.md)
- 2017-06-30 to 2017-09-30 | money | shares_outstanding | 590,972,792 shares | superseded | [clm_3B6D07BA6835](/claim/clm_3B6D07BA6835.md)
- 2017-06-30 to 2017-09-30 | money | total_assets | 78,510,000,000 United States dollar | superseded | [clm_3F1851405C67](/claim/clm_3F1851405C67.md)
- 2017-06-30 to 2017-09-30 | money | total_equity | 14,079,000,000 United States dollar | superseded | [clm_EA5D9655CB68](/claim/clm_EA5D9655CB68.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_operating_income | 1,577,000,000 United States dollar | superseded | [clm_B57698BE5E64](/claim/clm_B57698BE5E64.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_research_and_development | 455,000,000 United States dollar | superseded | [clm_EE23F07AC5BF](/claim/clm_EE23F07AC5BF.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 11,413,000,000 United States dollar | superseded | [clm_5251452F7BC1](/claim/clm_5251452F7BC1.md)
- 2017-09-30 to 2017-12-31 | money | shares_outstanding | 594,933,582 shares | superseded | [clm_3F6ACA0AAC27](/claim/clm_3F6ACA0AAC27.md)
- 2017-09-30 to 2017-12-31 | money | total_assets | 78,560,000,000 United States dollar | superseded | [clm_370B036A1AC7](/claim/clm_370B036A1AC7.md)
- 2017-09-30 to 2017-12-31 | money | total_equity | 15,697,000,000 United States dollar | superseded | [clm_0D9A004E063B](/claim/clm_0D9A004E063B.md)
- 2017-12-31 to 2018-12-31 | money | operating_income | 4,406,000,000 United States dollar | superseded | [clm_304FDE1EE8C4](/claim/clm_304FDE1EE8C4.md)
- 2017-12-31 to 2018-12-31 | money | research_and_development | 1,905,000,000 United States dollar | superseded | [clm_543ADA310CAF](/claim/clm_543ADA310CAF.md)
- 2017-12-31 to 2018-12-31 | money | revenue | 45,462,000,000 United States dollar | superseded | [clm_9E8F8E9D8B81](/claim/clm_9E8F8E9D8B81.md)
- 2017-12-31 to 2018-03-31 | money | shares_outstanding | 597,625,772 shares | superseded | [clm_9B54409A9AE3](/claim/clm_9B54409A9AE3.md)
- 2017-12-31 to 2018-03-31 | money | total_assets | 76,962,000,000 United States dollar | superseded | [clm_5118FCBE44CC](/claim/clm_5118FCBE44CC.md)

## 2018

- 2018-01-01 to 2018-03-31 | money | total_equity | 13,719,000,000 United States dollar | superseded | [clm_017CE288C572](/claim/clm_017CE288C572.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_operating_income | 2,108,000,000 United States dollar | superseded | [clm_4F7F24F116D5](/claim/clm_4F7F24F116D5.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 443,000,000 United States dollar | superseded | [clm_A2C479463A26](/claim/clm_A2C479463A26.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 12,859,000,000 United States dollar | superseded | [clm_BA5AA36D2423](/claim/clm_BA5AA36D2423.md)
- 2018-03-31 to 2018-06-30 | money | shares_outstanding | 597,904,900 shares | superseded | [clm_5DE9B3A4032D](/claim/clm_5DE9B3A4032D.md)
- 2018-03-31 to 2018-06-30 | money | total_assets | 78,014,000,000 United States dollar | superseded | [clm_A891E687582F](/claim/clm_A891E687582F.md)
- 2018-03-31 to 2018-06-30 | money | total_equity | 15,272,000,000 United States dollar | superseded | [clm_41D1A8E96F3E](/claim/clm_41D1A8E96F3E.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_operating_income | 2,167,000,000 United States dollar | superseded | [clm_431D0DE99FE2](/claim/clm_431D0DE99FE2.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 462,000,000 United States dollar | superseded | [clm_8ECC5ABC1EA9](/claim/clm_8ECC5ABC1EA9.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 14,011,000,000 United States dollar | superseded | [clm_C22AD382F4D1](/claim/clm_C22AD382F4D1.md)
- 2018-06-30 to 2018-09-30 | money | shares_outstanding | 594,325,388 shares | superseded | [clm_8A083CAC1B2F](/claim/clm_8A083CAC1B2F.md)
- 2018-06-30 to 2018-09-30 | money | total_assets | 78,987,000,000 United States dollar | superseded | [clm_BDCB234BDCDD](/claim/clm_BDCB234BDCDD.md)
- 2018-06-30 to 2018-09-30 | money | total_equity | 14,942,000,000 United States dollar | superseded | [clm_C5E7E0E3952A](/claim/clm_C5E7E0E3952A.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_operating_income | 2,135,000,000 United States dollar | superseded | [clm_822D5E1F08B1](/claim/clm_822D5E1F08B1.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 479,000,000 United States dollar | superseded | [clm_9EDE5462DFA9](/claim/clm_9EDE5462DFA9.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 13,510,000,000 United States dollar | superseded | [clm_6AB7E873F592](/claim/clm_6AB7E873F592.md)
- 2018-09-30 to 2018-12-31 | money | shares_outstanding | 590,106,711 shares | superseded | [clm_3C4125968432](/claim/clm_3C4125968432.md)
- 2018-09-30 to 2018-12-31 | money | total_assets | 78,209,000,000 United States dollar | superseded | [clm_87D4776EA4D2](/claim/clm_87D4776EA4D2.md)
- 2018-09-30 to 2018-12-31 | money | total_equity | 15,890,000,000 United States dollar | superseded | [clm_9BAE65CD19F5](/claim/clm_9BAE65CD19F5.md)
- 2018-12-31 to 2019-12-31 | money | operating_income | 8,293,000,000 United States dollar | superseded | [clm_F8FC10CE19DF](/claim/clm_F8FC10CE19DF.md)
- 2018-12-31 to 2019-12-31 | money | research_and_development | 1,850,000,000 United States dollar | superseded | [clm_B2E8F5041E4E](/claim/clm_B2E8F5041E4E.md)
- 2018-12-31 to 2019-12-31 | money | revenue | 54,722,000,000 United States dollar | superseded | [clm_19D39845043A](/claim/clm_19D39845043A.md)
- 2018-12-31 to 2019-03-31 | money | shares_outstanding | 575,542,738 shares | superseded | [clm_D2D3235C7B09](/claim/clm_D2D3235C7B09.md)
- 2018-12-31 to 2019-03-31 | money | total_assets | 78,509,000,000 United States dollar | superseded | [clm_01621DE770FC](/claim/clm_01621DE770FC.md)
- 2018-12-31 to 2019-01-01 | money | total_equity | 14,080,000,000 United States dollar | superseded | [clm_E79834A25C2E](/claim/clm_E79834A25C2E.md)

## 2019

- 2019-01-01 to 2019-03-31 | money | total_equity | 14,315,000,000 United States dollar | superseded | [clm_8736430A6482](/claim/clm_8736430A6482.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_operating_income | 2,207,000,000 United States dollar | superseded | [clm_935C61EAC989](/claim/clm_935C61EAC989.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 435,000,000 United States dollar | superseded | [clm_AD1232A1B84E](/claim/clm_AD1232A1B84E.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 13,466,000,000 United States dollar | superseded | [clm_32948A72A426](/claim/clm_32948A72A426.md)
- 2019-03-31 to 2019-06-30 | money | shares_outstanding | 571,702,278 shares | superseded | [clm_9488418F3A3E](/claim/clm_9488418F3A3E.md)
- 2019-03-31 to 2019-06-30 | money | total_assets | 78,726,000,000 United States dollar | superseded | [clm_5D33F8330AB9](/claim/clm_5D33F8330AB9.md)
- 2019-03-31 to 2019-06-30 | money | total_equity | 15,478,000,000 United States dollar | superseded | [clm_65D2BF10219A](/claim/clm_65D2BF10219A.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_operating_income | 2,213,000,000 United States dollar | superseded | [clm_7BFABD0F9F1F](/claim/clm_7BFABD0F9F1F.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 441,000,000 United States dollar | superseded | [clm_5AEF388DB4C5](/claim/clm_5AEF388DB4C5.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 14,432,000,000 United States dollar | superseded | [clm_CB3E0FA06F3C](/claim/clm_CB3E0FA06F3C.md)
- 2019-06-30 to 2019-09-30 | money | shares_outstanding | 562,589,191 shares | superseded | [clm_8B5D09196250](/claim/clm_8B5D09196250.md)
- 2019-06-30 to 2019-09-30 | money | total_assets | 79,187,000,000 United States dollar | superseded | [clm_BD6D5FA20BC5](/claim/clm_BD6D5FA20BC5.md)
- 2019-06-30 to 2019-09-30 | money | total_equity | 14,878,000,000 United States dollar | superseded | [clm_9D722F4565DE](/claim/clm_9D722F4565DE.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_operating_income | 2,020,000,000 United States dollar | superseded | [clm_87CC73A4F061](/claim/clm_87CC73A4F061.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 431,000,000 United States dollar | superseded | [clm_1DF922235E0B](/claim/clm_1DF922235E0B.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 12,758,000,000 United States dollar | superseded | [clm_C2CD2F5313FE](/claim/clm_C2CD2F5313FE.md)
- 2019-09-30 to 2019-12-31 | money | shares_outstanding | 552,658,387 shares | superseded | [clm_0798507558BD](/claim/clm_0798507558BD.md)
- 2019-09-30 to 2019-12-31 | money | total_assets | 77,993,000,000 United States dollar | superseded | [clm_622F41A6722D](/claim/clm_622F41A6722D.md)
- 2019-09-30 to 2019-12-31 | money | total_equity | 14,993,000,000 United States dollar | superseded | [clm_C1C4CC145197](/claim/clm_C1C4CC145197.md)
- 2019-12-31 to 2020-12-31 | money | operating_income | 8,290,000,000 United States dollar | superseded | [clm_FF794BB12A82](/claim/clm_FF794BB12A82.md)
- 2019-12-31 to 2020-12-31 | money | research_and_development | 1,693,000,000 United States dollar | superseded | [clm_7EF591021FEF](/claim/clm_7EF591021FEF.md)
- 2019-12-31 to 2020-12-31 | money | revenue | 53,800,000,000 United States dollar | superseded | [clm_CDA49E537DB0](/claim/clm_CDA49E537DB0.md)
- 2019-12-31 to 2020-03-31 | money | shares_outstanding | 550,082,610 shares | superseded | [clm_39AF8423589D](/claim/clm_39AF8423589D.md)
- 2019-12-31 to 2020-03-31 | money | total_assets | 78,453,000,000 United States dollar | superseded | [clm_8E1F717C0ED1](/claim/clm_8E1F717C0ED1.md)
- 2019-12-31 to 2020-03-31 | money | total_equity | 14,629,000,000 United States dollar | superseded | [clm_D571AE74A147](/claim/clm_D571AE74A147.md)

## 2020

- 2020-03-31 to 2020-06-30 | money | quarterly_operating_income | 1,404,000,000 United States dollar | superseded | [clm_3FEEE7B5F8A9](/claim/clm_3FEEE7B5F8A9.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 356,000,000 United States dollar | superseded | [clm_159954DBBA3B](/claim/clm_159954DBBA3B.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 10,635,000,000 United States dollar | superseded | [clm_3B4B5C9BAC8C](/claim/clm_3B4B5C9BAC8C.md)
- 2020-03-31 to 2020-06-30 | money | shares_outstanding | 541,951,509 shares | superseded | [clm_CEC95FDE649E](/claim/clm_CEC95FDE649E.md)
- 2020-03-31 to 2020-06-30 | money | total_assets | 75,894,000,000 United States dollar | superseded | [clm_6E009A9A15AF](/claim/clm_6E009A9A15AF.md)
- 2020-03-31 to 2020-06-30 | money | total_equity | 14,239,000,000 United States dollar | superseded | [clm_7B5B45A334B1](/claim/clm_7B5B45A334B1.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_operating_income | 784,000,000 United States dollar | superseded | [clm_CFC27A327827](/claim/clm_CFC27A327827.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 341,000,000 United States dollar | superseded | [clm_44AED945C879](/claim/clm_44AED945C879.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 9,997,000,000 United States dollar | superseded | [clm_08AEE26AAD37](/claim/clm_08AEE26AAD37.md)
- 2020-06-30 to 2020-09-30 | money | shares_outstanding | 541,506,575 shares | superseded | [clm_981A25BEB0AC](/claim/clm_981A25BEB0AC.md)
- 2020-06-30 to 2020-09-30 | money | total_assets | 76,566,000,000 United States dollar | superseded | [clm_43076A3756C4](/claim/clm_43076A3756C4.md)
- 2020-06-30 to 2020-09-30 | money | total_equity | 13,777,000,000 United States dollar | superseded | [clm_1672E2A37C66](/claim/clm_1672E2A37C66.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_operating_income | 985,000,000 United States dollar | superseded | [clm_27E60DE144B6](/claim/clm_27E60DE144B6.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 344,000,000 United States dollar | superseded | [clm_56AF093D5559](/claim/clm_56AF093D5559.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 9,881,000,000 United States dollar | superseded | [clm_B178BABB0A6E](/claim/clm_B178BABB0A6E.md)
- 2020-09-30 to 2020-12-31 | money | shares_outstanding | 543,258,283 shares | superseded | [clm_9CCCEFCB6C13](/claim/clm_9CCCEFCB6C13.md)
- 2020-09-30 to 2020-12-31 | money | total_assets | 76,741,000,000 United States dollar | superseded | [clm_880C217AEAD5](/claim/clm_880C217AEAD5.md)
- 2020-09-30 to 2020-12-31 | money | total_equity | 14,994,000,000 United States dollar | superseded | [clm_4F859E1404BF](/claim/clm_4F859E1404BF.md)
- 2020-12-31 to 2021-09-30 | money | cash_and_equivalents | 9,352,000,000 United States dollar | superseded | [clm_D90763C8B4AF](/claim/clm_D90763C8B4AF.md)
- 2020-12-31 to 2021-12-31 | money | operating_income | 4,553,000,000 United States dollar | superseded | [clm_070043AE157B](/claim/clm_070043AE157B.md)
- 2020-12-31 to 2021-12-31 | money | research_and_development | 1,415,000,000 United States dollar | superseded | [clm_0754BA2ACA46](/claim/clm_0754BA2ACA46.md)
- 2020-12-31 to 2021-12-31 | money | revenue | 41,748,000,000 United States dollar | superseded | [clm_B4B393090CA3](/claim/clm_B4B393090CA3.md)
- 2020-12-31 to 2021-03-31 | money | shares_outstanding | 545,303,847 shares | superseded | [clm_898D77B57FCB](/claim/clm_898D77B57FCB.md)
- 2020-12-31 to 2021-03-31 | money | total_assets | 78,324,000,000 United States dollar | superseded | [clm_A02ADB3F464B](/claim/clm_A02ADB3F464B.md)
- 2020-12-31 to 2021-03-31 | money | total_equity | 15,378,000,000 United States dollar | superseded | [clm_B362DBD177DF](/claim/clm_B362DBD177DF.md)

## 2021

- 2021-03-31 to 2021-06-30 | money | quarterly_operating_income | 1,814,000,000 United States dollar | superseded | [clm_0E0F513D0529](/claim/clm_0E0F513D0529.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 374,000,000 United States dollar | superseded | [clm_CF96ED4430F6](/claim/clm_CF96ED4430F6.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 11,887,000,000 United States dollar | superseded | [clm_7A224088F029](/claim/clm_7A224088F029.md)
- 2021-03-31 to 2021-06-30 | money | shares_outstanding | 547,763,530 shares | superseded | [clm_E92A07D8D814](/claim/clm_E92A07D8D814.md)
- 2021-03-31 to 2021-06-30 | money | total_assets | 80,729,000,000 United States dollar | superseded | [clm_674D6F7F29B8](/claim/clm_674D6F7F29B8.md)
- 2021-03-31 to 2021-06-30 | money | total_equity | 16,617,000,000 United States dollar | superseded | [clm_2C3151F2177E](/claim/clm_2C3151F2177E.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_operating_income | 1,789,000,000 United States dollar | superseded | [clm_25C4FDB8DF1A](/claim/clm_25C4FDB8DF1A.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 446,000,000 United States dollar | superseded | [clm_41ECEF2B1AD2](/claim/clm_41ECEF2B1AD2.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 12,889,000,000 United States dollar | superseded | [clm_270F7BBFCB89](/claim/clm_270F7BBFCB89.md)
- 2021-06-30 to 2021-09-30 | money | shares_outstanding | 547,471,467 shares | superseded | [clm_1CB88AD7A38C](/claim/clm_1CB88AD7A38C.md)
- 2021-06-30 to 2021-09-30 | money | total_assets | 81,697,000,000 United States dollar | superseded | [clm_50200B6B20DF](/claim/clm_50200B6B20DF.md)
- 2021-06-30 to 2021-09-30 | money | total_equity | 16,880,000,000 United States dollar | superseded | [clm_A050B296C86C](/claim/clm_A050B296C86C.md)
- 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 9,446,000,000 United States dollar | superseded | [clm_A2FF02B66FAD](/claim/clm_A2FF02B66FAD.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_operating_income | 1,664,000,000 United States dollar | superseded | [clm_453187540479](/claim/clm_453187540479.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 427,000,000 United States dollar | superseded | [clm_1A1092082A2A](/claim/clm_1A1092082A2A.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 12,397,000,000 United States dollar | superseded | [clm_C733AC7422FD](/claim/clm_C733AC7422FD.md)
- 2021-09-30 to 2021-12-31 | money | shares_outstanding | 540,941,600 shares | superseded | [clm_71FCD2E0D767](/claim/clm_71FCD2E0D767.md)
- 2021-09-30 to 2021-12-31 | money | total_assets | 80,784,000,000 United States dollar | superseded | [clm_B41622455796](/claim/clm_B41622455796.md)
- 2021-09-30 to 2021-12-31 | money | total_equity | 16,695,000,000 United States dollar | superseded | [clm_53E7276B9998](/claim/clm_53E7276B9998.md)
- 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 9,254,000,000 United States dollar | superseded | [clm_B882004FC673](/claim/clm_B882004FC673.md)
- 2021-12-31 to 2022-12-31 | money | operating_income | 6,878,000,000 United States dollar | superseded | [clm_F8F6BC0AA8BF](/claim/clm_F8F6BC0AA8BF.md)
- 2021-12-31 to 2022-12-31 | money | research_and_development | 1,686,000,000 United States dollar | superseded | [clm_E8AA37C58CD6](/claim/clm_E8AA37C58CD6.md)
- 2021-12-31 to 2022-12-31 | money | revenue | 50,971,000,000 United States dollar | superseded | [clm_277B6B17D286](/claim/clm_277B6B17D286.md)
- 2021-12-31 to 2022-03-31 | money | shares_outstanding | 535,888,051 shares | superseded | [clm_D65386969745](/claim/clm_D65386969745.md)
- 2021-12-31 to 2022-03-31 | money | total_assets | 82,793,000,000 United States dollar | superseded | [clm_69F3E258F1D1](/claim/clm_69F3E258F1D1.md)
- 2021-12-31 to 2022-03-31 | money | total_equity | 16,516,000,000 United States dollar | superseded | [clm_9E8DD24E3F1B](/claim/clm_9E8DD24E3F1B.md)

## 2022

- 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 6,526,000,000 United States dollar | superseded | [clm_3BD1C2E4CB98](/claim/clm_3BD1C2E4CB98.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_operating_income | 1,855,000,000 United States dollar | superseded | [clm_13140CB70B9A](/claim/clm_13140CB70B9A.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_research_and_development | 457,000,000 United States dollar | superseded | [clm_F5287AF5F70D](/claim/clm_F5287AF5F70D.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 13,589,000,000 United States dollar | superseded | [clm_AA224A2F550C](/claim/clm_AA224A2F550C.md)
- 2022-03-31 to 2022-06-30 | money | shares_outstanding | 533,353,205 shares | superseded | [clm_5773C7FE2AC7](/claim/clm_5773C7FE2AC7.md)
- 2022-03-31 to 2022-06-30 | money | total_assets | 82,276,000,000 United States dollar | superseded | [clm_4D3CF51690AE](/claim/clm_4D3CF51690AE.md)
- 2022-03-31 to 2022-06-30 | money | total_equity | 17,097,000,000 United States dollar | superseded | [clm_183C4C681E62](/claim/clm_183C4C681E62.md)
- 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 6,014,000,000 United States dollar | superseded | [clm_58224803FC4E](/claim/clm_58224803FC4E.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_operating_income | 1,944,000,000 United States dollar | superseded | [clm_569B62CCBA77](/claim/clm_569B62CCBA77.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_research_and_development | 480,000,000 United States dollar | superseded | [clm_255B2211DB52](/claim/clm_255B2211DB52.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 14,247,000,000 United States dollar | superseded | [clm_79113B40B8ED](/claim/clm_79113B40B8ED.md)
- 2022-06-30 to 2022-09-30 | money | shares_outstanding | 527,909,143 shares | superseded | [clm_A644978D1B39](/claim/clm_A644978D1B39.md)
- 2022-06-30 to 2022-09-30 | money | total_assets | 81,107,000,000 United States dollar | superseded | [clm_997DEB1E7712](/claim/clm_997DEB1E7712.md)
- 2022-06-30 to 2022-09-30 | money | total_equity | 15,759,000,000 United States dollar | superseded | [clm_1D2FB702C702](/claim/clm_1D2FB702C702.md)
- 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 6,346,000,000 United States dollar | superseded | [clm_4A597B13FDC3](/claim/clm_4A597B13FDC3.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_operating_income | 2,425,000,000 United States dollar | superseded | [clm_76F0115062CB](/claim/clm_76F0115062CB.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 476,000,000 United States dollar | superseded | [clm_65F2E35EAA6F](/claim/clm_65F2E35EAA6F.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 14,994,000,000 United States dollar | superseded | [clm_48EEE656230B](/claim/clm_48EEE656230B.md)
- 2022-09-30 to 2022-12-31 | money | shares_outstanding | 520,409,355 shares | superseded | [clm_74DDF54F1A69](/claim/clm_74DDF54F1A69.md)
- 2022-09-30 to 2022-12-31 | money | total_assets | 80,907,000,000 United States dollar | superseded | [clm_0B2E689968AB](/claim/clm_0B2E689968AB.md)
- 2022-09-30 to 2022-12-31 | money | total_equity | 15,622,000,000 United States dollar | superseded | [clm_B4756209EE13](/claim/clm_B4756209EE13.md)
- 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 7,004,000,000 United States dollar | superseded | [clm_26B2A454F750](/claim/clm_26B2A454F750.md)
- 2022-12-31 to 2023-12-31 | money | operating_income | 7,904,000,000 United States dollar | superseded | [clm_4F1A58D558F3](/claim/clm_4F1A58D558F3.md)
- 2022-12-31 to 2023-12-31 | money | research_and_development | 1,814,000,000 United States dollar | superseded | [clm_1D0F344F5094](/claim/clm_1D0F344F5094.md)
- 2022-12-31 to 2023-12-31 | money | revenue | 59,427,000,000 United States dollar | superseded | [clm_C0CFDB0071E4](/claim/clm_C0CFDB0071E4.md)
- 2022-12-31 to 2023-03-31 | money | shares_outstanding | 516,345,490 shares | superseded | [clm_6CD1CFC3D8AD](/claim/clm_6CD1CFC3D8AD.md)
- 2022-12-31 to 2023-03-31 | money | total_assets | 81,943,000,000 United States dollar | superseded | [clm_01446BC00F9D](/claim/clm_01446BC00F9D.md)
- 2022-12-31 to 2023-03-31 | money | total_equity | 15,891,000,000 United States dollar | superseded | [clm_36B6D81A9C3E](/claim/clm_36B6D81A9C3E.md)

## 2023

- 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 6,789,000,000 United States dollar | superseded | [clm_BE648C3304C6](/claim/clm_BE648C3304C6.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | 2,731,000,000 United States dollar | superseded | [clm_572E7768D4DF](/claim/clm_572E7768D4DF.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 472,000,000 United States dollar | superseded | [clm_3EFAA2E01F86](/claim/clm_3EFAA2E01F86.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 15,862,000,000 United States dollar | superseded | [clm_97E95BCC9F88](/claim/clm_97E95BCC9F88.md)
- 2023-03-31 to 2023-06-30 | money | shares_outstanding | 515,920,061 shares | superseded | [clm_B9DE9D02A25C](/claim/clm_B9DE9D02A25C.md)
- 2023-03-31 to 2023-06-30 | money | total_assets | 83,649,000,000 United States dollar | superseded | [clm_FB11C7EB91B8](/claim/clm_FB11C7EB91B8.md)
- 2023-03-31 to 2023-06-30 | money | total_equity | 18,170,000,000 United States dollar | superseded | [clm_420EE3BF7496](/claim/clm_420EE3BF7496.md)
- 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 7,387,000,000 United States dollar | superseded | [clm_675CFB754C8D](/claim/clm_675CFB754C8D.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_operating_income | 3,652,000,000 United States dollar | superseded | [clm_62D9606B1FF5](/claim/clm_62D9606B1FF5.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_research_and_development | 528,000,000 United States dollar | superseded | [clm_C164C063E823](/claim/clm_C164C063E823.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 17,318,000,000 United States dollar | superseded | [clm_D266C326D279](/claim/clm_D266C326D279.md)
- 2023-06-30 to 2023-09-30 | money | shares_outstanding | 510,143,097 shares | superseded | [clm_1F58403739BE](/claim/clm_1F58403739BE.md)
- 2023-06-30 to 2023-09-30 | money | total_assets | 85,427,000,000 United States dollar | superseded | [clm_0E0CAE54CB31](/claim/clm_0E0CAE54CB31.md)
- 2023-06-30 to 2023-09-30 | money | total_equity | 18,256,000,000 United States dollar | superseded | [clm_4A2FEC376D17](/claim/clm_4A2FEC376D17.md)
- 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 6,545,000,000 United States dollar | superseded | [clm_93861A116F0E](/claim/clm_93861A116F0E.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_operating_income | 3,449,000,000 United States dollar | superseded | [clm_9F73E2002152](/claim/clm_9F73E2002152.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_research_and_development | 554,000,000 United States dollar | superseded | [clm_ED42E9400CB4](/claim/clm_ED42E9400CB4.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 16,810,000,000 United States dollar | superseded | [clm_8FDDAF2AE235](/claim/clm_8FDDAF2AE235.md)
- 2023-09-30 to 2023-12-31 | money | shares_outstanding | 509,084,743 shares | superseded | [clm_B5C406D6517D](/claim/clm_B5C406D6517D.md)
- 2023-09-30 to 2023-12-31 | money | total_assets | 86,791,000,000 United States dollar | superseded | [clm_13DE249B11C3](/claim/clm_13DE249B11C3.md)
- 2023-09-30 to 2023-12-31 | money | total_equity | 20,507,000,000 United States dollar | superseded | [clm_808D61E082E7](/claim/clm_808D61E082E7.md)
- 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 6,978,000,000 United States dollar | superseded | [clm_02C4C1E8086D](/claim/clm_02C4C1E8086D.md)
- 2023-12-31 to 2024-12-31 | money | operating_income | 12,966,000,000 United States dollar | superseded | [clm_2B5D86F8E26A](/claim/clm_2B5D86F8E26A.md)
- 2023-12-31 to 2024-12-31 | money | research_and_development | 2,108,000,000 United States dollar | superseded | [clm_CDD6E22CEA51](/claim/clm_CDD6E22CEA51.md)
- 2023-12-31 to 2024-12-31 | money | revenue | 67,060,000,000 United States dollar | superseded | [clm_14F5A4AA2518](/claim/clm_14F5A4AA2518.md)
- 2023-12-31 to 2024-03-31 | money | shares_outstanding | 499,377,269 shares | superseded | [clm_7BAE41D9F79E](/claim/clm_7BAE41D9F79E.md)
- 2023-12-31 to 2024-03-31 | money | total_assets | 87,476,000,000 United States dollar | superseded | [clm_15A2940E7F88](/claim/clm_15A2940E7F88.md)
- 2023-12-31 to 2024-03-31 | money | total_equity | 19,503,000,000 United States dollar | superseded | [clm_3406DDE8250E](/claim/clm_3406DDE8250E.md)

## 2024

- 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 4,959,000,000 United States dollar | superseded | [clm_C89FA7A4B4E1](/claim/clm_C89FA7A4B4E1.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_operating_income | 3,519,000,000 United States dollar | superseded | [clm_521385A18EBB](/claim/clm_521385A18EBB.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_research_and_development | 520,000,000 United States dollar | superseded | [clm_B46F1586BEF0](/claim/clm_B46F1586BEF0.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 15,799,000,000 United States dollar | superseded | [clm_A73E414B0405](/claim/clm_A73E414B0405.md)
- 2024-03-31 to 2024-06-30 | money | shares_outstanding | 489,272,920 shares | superseded | [clm_6AD7ABE42179](/claim/clm_6AD7ABE42179.md)
- 2024-03-31 to 2024-06-30 | money | total_assets | 83,741,000,000 United States dollar | superseded | [clm_B1A3223BFB4C](/claim/clm_B1A3223BFB4C.md)
- 2024-03-31 to 2024-06-30 | money | total_equity | 17,645,000,000 United States dollar | superseded | [clm_12769D7171E7](/claim/clm_12769D7171E7.md)
- 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 4,341,000,000 United States dollar | superseded | [clm_0E3D2EA4A64C](/claim/clm_0E3D2EA4A64C.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_operating_income | 3,482,000,000 United States dollar | superseded | [clm_1E79B762E998](/claim/clm_1E79B762E998.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_research_and_development | 535,000,000 United States dollar | superseded | [clm_DD2B8EE85680](/claim/clm_DD2B8EE85680.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 16,689,000,000 United States dollar | superseded | [clm_7B47ED6175DA](/claim/clm_7B47ED6175DA.md)
- 2024-06-30 to 2024-09-30 | money | shares_outstanding | 484,898,116 shares | superseded | [clm_DCD30127544B](/claim/clm_DCD30127544B.md)
- 2024-06-30 to 2024-09-30 | money | total_assets | 83,336,000,000 United States dollar | superseded | [clm_BCB7E0614D93](/claim/clm_BCB7E0614D93.md)
- 2024-06-30 to 2024-09-30 | money | total_equity | 17,136,000,000 United States dollar | superseded | [clm_6372A0D8C0E4](/claim/clm_6372A0D8C0E4.md)
- 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 5,638,000,000 United States dollar | superseded | [clm_558DD9DB7EC4](/claim/clm_558DD9DB7EC4.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_operating_income | 3,147,000,000 United States dollar | superseded | [clm_72F5AD35CDEB](/claim/clm_72F5AD35CDEB.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_research_and_development | 533,000,000 United States dollar | superseded | [clm_33918F72DD3D](/claim/clm_33918F72DD3D.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 16,106,000,000 United States dollar | superseded | [clm_38A39435D41A](/claim/clm_38A39435D41A.md)
- 2024-09-30 to 2024-12-31 | money | shares_outstanding | 482,802,488 shares | superseded | [clm_EABA45F81385](/claim/clm_EABA45F81385.md)
- 2024-09-30 to 2024-12-31 | money | total_assets | 86,273,000,000 United States dollar | superseded | [clm_019376FC7111](/claim/clm_019376FC7111.md)
- 2024-09-30 to 2024-12-31 | money | total_equity | 19,403,000,000 United States dollar | superseded | [clm_5FC63FECEDF7](/claim/clm_5FC63FECEDF7.md)
- 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 6,889,000,000 United States dollar | superseded | [clm_6B6BAE7312AC](/claim/clm_6B6BAE7312AC.md)
- 2024-12-31 to 2025-12-31 | money | operating_income | 13,072,000,000 United States dollar | superseded | [clm_ACF0FF9AF378](/claim/clm_ACF0FF9AF378.md)
- 2024-12-31 to 2025-12-31 | money | research_and_development | 2,107,000,000 United States dollar | superseded | [clm_52144B372F95](/claim/clm_52144B372F95.md)
- 2024-12-31 to 2025-12-31 | money | revenue | 64,809,000,000 United States dollar | superseded | [clm_0495DDC1CEC8](/claim/clm_0495DDC1CEC8.md)
- 2024-12-31 to 2025-03-31 | money | shares_outstanding | 477,932,024 shares | superseded | [clm_169FE487EB44](/claim/clm_169FE487EB44.md)
- 2024-12-31 to 2025-03-31 | money | total_assets | 87,764,000,000 United States dollar | superseded | [clm_9692CFD0294B](/claim/clm_9692CFD0294B.md)
- 2024-12-31 to 2025-03-31 | money | total_equity | 19,494,000,000 United States dollar | superseded | [clm_C17C47B32D89](/claim/clm_C17C47B32D89.md)

## 2025

- 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 3,562,000,000 United States dollar | superseded | [clm_20C560071561](/claim/clm_20C560071561.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_operating_income | 2,579,000,000 United States dollar | superseded | [clm_00659B938D11](/claim/clm_00659B938D11.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_research_and_development | 480,000,000 United States dollar | superseded | [clm_0F01AA0528E0](/claim/clm_0F01AA0528E0.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 14,249,000,000 United States dollar | superseded | [clm_BCA4E0A06E70](/claim/clm_BCA4E0A06E70.md)
- 2025-03-31 to 2025-06-30 | money | shares_outstanding | 471,041,788 shares | superseded | [clm_8FD8670E2723](/claim/clm_8FD8670E2723.md)
- 2025-03-31 to 2025-06-30 | money | total_assets | 84,974,000,000 United States dollar | superseded | [clm_C06BC53745A2](/claim/clm_C06BC53745A2.md)
- 2025-03-31 to 2025-06-30 | money | total_equity | 18,070,000,000 United States dollar | superseded | [clm_75CDA32D11F7](/claim/clm_75CDA32D11F7.md)
- 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 5,442,000,000 United States dollar | superseded | [clm_246D0FAA76CF](/claim/clm_246D0FAA76CF.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_operating_income | 2,860,000,000 United States dollar | superseded | [clm_29D20F11BC04](/claim/clm_29D20F11BC04.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_research_and_development | 551,000,000 United States dollar | superseded | [clm_D1D9083F1291](/claim/clm_D1D9083F1291.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 16,569,000,000 United States dollar | superseded | [clm_1CA5ED5FE11B](/claim/clm_1CA5ED5FE11B.md)
- 2025-06-30 to 2025-09-30 | money | shares_outstanding | 468,478,923 shares | superseded | [clm_431C8E558C2C](/claim/clm_431C8E558C2C.md)
- 2025-06-30 to 2025-09-30 | money | total_assets | 90,325,000,000 United States dollar | superseded | [clm_73109FE4BED3](/claim/clm_73109FE4BED3.md)
- 2025-06-30 to 2025-09-30 | money | total_equity | 18,663,000,000 United States dollar | superseded | [clm_F3E50D51BF77](/claim/clm_F3E50D51BF77.md)
- 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 7,538,000,000 United States dollar | superseded | [clm_3025EDD70A52](/claim/clm_3025EDD70A52.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_operating_income | 3,052,000,000 United States dollar | superseded | [clm_0063D598349D](/claim/clm_0063D598349D.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_research_and_development | 555,000,000 United States dollar | superseded | [clm_75C9A606F2C5](/claim/clm_75C9A606F2C5.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 17,638,000,000 United States dollar | superseded | [clm_606A21CEEA88](/claim/clm_606A21CEEA88.md)
- 2025-09-30 to 2025-12-31 | money | shares_outstanding | 467,979,596 shares | superseded | [clm_46821C795317](/claim/clm_46821C795317.md)
- 2025-09-30 to 2025-12-31 | money | total_assets | 93,722,000,000 United States dollar | superseded | [clm_E2F15A09CC41](/claim/clm_E2F15A09CC41.md)
- 2025-09-30 to 2025-12-31 | money | total_equity | 20,659,000,000 United States dollar | superseded | [clm_BF384250B712](/claim/clm_BF384250B712.md)
- 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 9,980,000,000 United States dollar | superseded | [clm_B0AB8BAD26CB](/claim/clm_B0AB8BAD26CB.md)
- 2025-12-31 | money | operating_income | 11,151,000,000 United States dollar | valid | [clm_7C7C5D9768CC](/claim/clm_7C7C5D9768CC.md)
- 2025-12-31 | money | research_and_development | 2,148,000,000 United States dollar | valid | [clm_8B58C50EE90B](/claim/clm_8B58C50EE90B.md)
- 2025-12-31 | money | revenue | 67,589,000,000 United States dollar | valid | [clm_80B5D401673B](/claim/clm_80B5D401673B.md)
- 2025-12-31 to 2026-03-31 | money | shares_outstanding | 465,287,332 shares | superseded | [clm_ECB4A418288F](/claim/clm_ECB4A418288F.md)
- 2025-12-31 to 2026-03-31 | money | total_assets | 98,585,000,000 United States dollar | superseded | [clm_2385E4A2742C](/claim/clm_2385E4A2742C.md)
- 2025-12-31 to 2026-03-31 | money | total_equity | 21,318,000,000 United States dollar | superseded | [clm_6F45E0A9F932](/claim/clm_6F45E0A9F932.md)

## 2026

- 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 4,072,000,000 United States dollar | superseded | [clm_45C6A5A5F6F7](/claim/clm_45C6A5A5F6F7.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_operating_income | 3,085,000,000 United States dollar | superseded | [clm_1C70F2CE3A4A](/claim/clm_1C70F2CE3A4A.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_research_and_development | 537,000,000 United States dollar | superseded | [clm_C2C1ED498A8A](/claim/clm_C2C1ED498A8A.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 17,415,000,000 United States dollar | superseded | [clm_650EDBC57F28](/claim/clm_650EDBC57F28.md)
- 2026-03-31 to 2026-06-30 | money | shares_outstanding | 460,637,026 shares | superseded | [clm_1862EF4CDC3E](/claim/clm_1862EF4CDC3E.md)
- 2026-03-31 to 2026-06-30 | money | total_assets | 95,550,000,000 United States dollar | superseded | [clm_E269F4DECE65](/claim/clm_E269F4DECE65.md)
- 2026-03-31 to 2026-06-30 | money | total_equity | 18,660,000,000 United States dollar | superseded | [clm_751CA6D3C4A2](/claim/clm_751CA6D3C4A2.md)
- 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 6,713,000,000 United States dollar | superseded | [clm_A98CE0AA67B2](/claim/clm_A98CE0AA67B2.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_operating_income | 4,295,000,000 United States dollar | superseded | [clm_E4D66919279E](/claim/clm_E4D66919279E.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_research_and_development | 616,000,000 United States dollar | superseded | [clm_9F2271DE52E2](/claim/clm_9F2271DE52E2.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 20,543,000,000 United States dollar | superseded | [clm_EAC9B4C41D45](/claim/clm_EAC9B4C41D45.md)
- 2026-06-30 to 2026-09-30 | money | shares_outstanding | 459,674,889 shares | superseded | [clm_7CA2B01F59AE](/claim/clm_7CA2B01F59AE.md)
- 2026-06-30 to 2026-09-30 | money | total_assets | 102,609,000,000 United States dollar | superseded | [clm_48BB890275D5](/claim/clm_48BB890275D5.md)
- 2026-06-30 to 2026-09-30 | money | total_equity | 19,394,000,000 United States dollar | superseded | [clm_5822B3F6385E](/claim/clm_5822B3F6385E.md)
- 2026-09-30 | money | cash_and_equivalents | 7,929,000,000 United States dollar | valid | [clm_52E24A4CE4AF](/claim/clm_52E24A4CE4AF.md)
- 2026-09-30 | money | quarterly_operating_income | 4,214,000,000 United States dollar | valid | [clm_FCA27F377023](/claim/clm_FCA27F377023.md)
- 2026-09-30 | money | quarterly_research_and_development | 596,000,000 United States dollar | valid | [clm_4812060A9372](/claim/clm_4812060A9372.md)
- 2026-09-30 | money | quarterly_revenue | 20,682,000,000 United States dollar | valid | [clm_841F4AAF1A55](/claim/clm_841F4AAF1A55.md)
- 2026-09-30 | money | shares_outstanding | 457,594,174 shares | valid | [clm_EC4EA4AEBDE0](/claim/clm_EC4EA4AEBDE0.md)
- 2026-09-30 | money | total_assets | 106,843,000,000 United States dollar | valid | [clm_6784F5150EF7](/claim/clm_6784F5150EF7.md)
- 2026-09-30 | money | total_equity | 21,482,000,000 United States dollar | valid | [clm_9746FCB715E2](/claim/clm_9746FCB715E2.md)

## undated

- undated | other | cik | 0000018230 | valid | [clm_103322238F9B](/claim/clm_103322238F9B.md)
- undated | other | fiscal_year_end | 12-31 | valid | [clm_F1BDA3C034D4](/claim/clm_F1BDA3C034D4.md)
- undated | other | headquarters | Irving | valid | [clm_7D4538A921D1](/claim/clm_7D4538A921D1.md)
- undated | other | listed_on | NYSE | valid | [clm_3ECFBE5C9D31](/claim/clm_3ECFBE5C9D31.md)
- undated | other | registrant_name | CATERPILLAR INC | valid | [clm_272BC677D4A4](/claim/clm_272BC677D4A4.md)
- undated | other | sic_industry | Construction Machinery & Equip (3531) | valid | [clm_3CCD40EF9B95](/claim/clm_3CCD40EF9B95.md)
- undated | other | state_of_incorporation | DE | valid | [clm_EB7C47F36932](/claim/clm_EB7C47F36932.md)
- undated | other | ticker | CAT | valid | [clm_3B1ABF5AB669](/claim/clm_3B1ABF5AB669.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.